NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.81% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.02% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 4.01% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.99% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.94% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 3.74% |
| MCK | McKesson Corporation | Healthcare | Medical Distribution | 3.71% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.27% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.12% |
| IDXX | IDEXX Laboratories Inc | Healthcare | Diagnostics & Research | 3.03% |
| 2269 | WuXi Biologics | Healthcare | Biotechnology | 2.85% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.70% |
| TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 2.59% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.50% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.50% | ||
| WAT | Waters Corporation | Healthcare | Diagnostics & Research | 2.47% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.46% |
| NOVN | Novartis AG | Healthcare | Drug Manufacturers - General | 2.32% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.26% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.24% |